These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21512501)

  • 1. [Treatment-resistant depressions in borderline psychiatry].
    Iastrebov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):47-50. PubMed ID: 21512501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined treatment of venlafaxine and quetiapine for treatment-resistant depression: a clinical study.
    Li X; Xing B; Yu E; Chen W; Wu H
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):157-60. PubMed ID: 23686035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
    Mazeh D; Melamed Y; Elizur A
    J Clin Psychopharmacol; 1999 Jun; 19(3):284-5. PubMed ID: 10350042
    [No Abstract]   [Full Text] [Related]  

  • 5. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
    Ivanets NN; Kinkulkina MA; Tikhonova YG; Iziumina TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):30-34. PubMed ID: 25909786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.
    Gonzalez-Pinto A; Gutierrez M; Gonzalez N; Elizagarate E; Perez de Heredia JL; Mico JA
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):206-9. PubMed ID: 11983797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of generalized anxiety disorder with venlafaxine: a series of 11 cases.
    Johnson MR; Emmanuel N; Crawford M; Lydiard RB; Villareal G
    J Clin Psychopharmacol; 1998 Oct; 18(5):418-9. PubMed ID: 9790161
    [No Abstract]   [Full Text] [Related]  

  • 9. [The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine].
    Poirier MF
    Encephale; 1999 Jun; 25 Spec No 2():55-7; discussion 58-61. PubMed ID: 10434160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial.
    Dahmen N; Marx J; Hopf HC; Tettenborn B; Röder R
    Stroke; 1999 Mar; 30(3):691-2. PubMed ID: 10066874
    [No Abstract]   [Full Text] [Related]  

  • 11. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
    Dursun SM; Devarajan S
    Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphoresis and pruritus with extended-release venlafaxine.
    Schwartz TL
    Ann Pharmacother; 1999 Sep; 33(9):1009. PubMed ID: 10492509
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine withdrawal symptoms.
    Benazzi F
    Can J Psychiatry; 1996 Sep; 41(7):487. PubMed ID: 8884044
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
    Mbaya P
    Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine induced akathisia: a case report.
    Grover S; Valaparla VL
    Indian J Pharmacol; 2014; 46(6):660-1. PubMed ID: 25538344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
    Rej S; Dew MA; Karp JF
    Pain Med; 2014 Jul; 15(7):1154-62. PubMed ID: 25040462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
    Rickels K; Pollack MH; Sheehan DV; Haskins JT
    Am J Psychiatry; 2000 Jun; 157(6):968-74. PubMed ID: 10831478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.